ALso some insight into the next 5 products to come out of the Adapt platform for surgeries.
Surely they would have an indication of what can be made or achieved.
Neethling would know and so would the CEO. It would have been ascertained when they took over.
Dura Mater has been quiet. Ear institute has been quiet. Stem cell work quiet.
Prob better off just ignoring this stock for a few years the way it's goin
Revenue $m, page-21
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.32 |
Change
-0.900(7.36%) |
Mkt cap ! $246.0M | |||
| Open | High | Low | Value | Volume |
| $12.20 | $12.22 | $11.21 | $112.3K | 9.566K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 120 | $11.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.45 | 209 | 3 |
View Market Depth
| Last trade - 11.42am 21/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |